T
Tango Therapeutics, Inc. (TNGX)
NGM – Real vaqt narxi. Valyuta: USD
31.47
+1.33 (4.41%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
Bozordan keyin: Jun 26, 2026, 7:44 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
31.47
+1.33 (4.41%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
30.85
-0.62 (-1.97%)
Bozordan keyin: Jun 26, 2026, 7:44 PM EDT
Tango Therapeutics, Inc., aniq onkologiya kompaniyasi, tibbiy ehtiyojlari qondirilmagan aniq bemorlar guruhlarida dorilarni kashf qilish va ishlab chiqishga qaratilgan. Kompaniya metiltioadenozin-kooperativ oqsil arginin metiltransferaza 5 (PRMT5) ingibitorlarini ishlab chiqadi, shu jumladan TNG462, bu oshqozon osti bezi va o'pka saratonini davolash uchun 1/2-bosqichli klinik sinovda; va TNG456, miyaga kiruvchi PRMT5 ingibitori, bu glialoblastomani davolash uchun. Kompaniya TNG260, repressor element-1 silencing transcription inhibitor ko-repressorini ishlab chiqmoqda, bu o'pka saratonini davolash uchun serin-treonin kinaz (STK) 11 yo'qolgan funksiyali mutatsiyalarining immunitetdan qochish ta'sirini bartaraf etishga qaratilgan. Kompaniya 2017-yilda tashkil etilgan va shtab-kvartirasi Boston, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Adam S. Crystal M.D., Ph.D. | President of Research & Development |
| Dr. Antoni Ribas M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| Dr. Barbara L. Weber M.D. | Founder & Executive Chair |
| Dr. Malte Peters M.D. | President, CEO & Director |
| Dr. William G. Kaelin Jr., M.D. | Founder & Member of Scientific Advisory Board |
| Mr. Jannik N. Andersen Ph.D. | Chief Scientific Officer |
| Mr. Matthew Gall M.B.A. | Chief Financial Officer |
| Ms. Daniella Beckman CPA | Executive Officer |
| Prof. Alan Ashworth FRS, Ph.D. | Founder & Member of Scientific Advisory Board |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-23 | 8-K | d79260d8k.htm |
| 2026-06-10 | 8-K | d81492d8k.htm |
| 2026-06-08 | 8-K | d158334d8k.htm |
| 2026-06-04 | 8-K | d149262d8k.htm |
| 2026-05-13 | 8-K | tngx-20260513.htm |
| 2026-05-13 | 10-Q | tngx-20260331.htm |
| 2026-05-08 | 8-K | d102174d8k.htm |
| 2026-04-17 | DEFA14A | d93491ddefa14a.htm |
| 2026-04-17 | DEF 14A | tngx-20260416.htm |
| 2026-04-17 | ARS | d145279dars.pdf |